Aramark director gains 34.551 dividend rights

A director of Aramark received a small grant of dividend equivalent rights linked to deferred stock units from the company’s quarterly dividend.

Rhea-AI Filing Summary

Aramark (ARMK) reported that director Kevin Wills acquired additional common stock-related rights on September 9, 2026 through a grant classified as a grant, award, or other acquisition tied to existing deferred stock units. The filing states this represents 34.551 dividend equivalent rights accruing from the company’s quarterly dividend, bringing his directly held common stock-related position to 21,974.546 shares after the transaction. These dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 34.551 shares

Grant/Award 1 txn

Insider Wills Kevin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	34.551	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,974.546 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Key Figures

Dividend equivalent rights acquired: 34.551 rights Holdings after transaction: 21,974.546 shares Reported transaction price: $0.0000 per share +1 more

4 metrics

Dividend equivalent rights acquired 34.551 rights Accrued on deferred stock units from Aramark’s quarterly dividend on September 9, 2026

Holdings after transaction 21,974.546 shares Total directly held common stock or equivalent units reported after the September 9, 2026 grant

Reported transaction price $0.0000 per share Grant of dividend equivalent rights classified as a grant, award, or other acquisition

Transaction date September 9, 2026 Date the dividend equivalent rights grant to Kevin Wills was effective

Key Terms

dividend equivalent rights, deferred stock units, quarterly dividend

3 terms

dividend equivalent rights financial

"Represents dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

deferred stock units financial

"accrued to the reporting person on deferred stock units held by the reporting person"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

quarterly dividend financial

"in connection with the Issuer's quarterly dividend and accrued to the reporting person"

A quarterly dividend is a payment a company gives to its shareholders four times a year, usually as a share of its profits. It's like getting a small bonus every few months for owning the company's stock, which can provide a steady income. Investors watch these payments to see how well a company is doing and whether it’s a good investment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Kevin Wills?

Aramark reported that director Kevin Wills acquired 34.551 dividend equivalent rights on September 9, 2026. These arose from the company’s quarterly dividend on deferred stock units he already holds.

How many Aramark (ARMK) shares or share-equivalent rights does Kevin Wills hold after this Form 4?

After the September 9, 2026 transaction, Kevin Wills is reported as directly holding 21,974.546 common stock or common stock-equivalent units in Aramark.

What are the 34.551 units reported in Kevin Wills’s Aramark (ARMK) Form 4?

The 34.551 units are dividend equivalent rights that accrued on deferred stock units held by Kevin Wills in connection with Aramark’s quarterly dividend. They follow the vesting schedule of the underlying awards.

Was the Aramark (ARMK) insider transaction by Kevin Wills part of a Rule 10b5-1 plan?

No. The filing indicates the Rule 10b5-1 checkbox is not marked, so no Rule 10b5-1 trading plan is reported for this acquisition of dividend equivalent rights.

Did Kevin Wills pay a cash price per share for the Aramark (ARMK) dividend equivalent rights?

No cash price is reported. The transaction is described as dividend equivalent rights in connection with Aramark’s quarterly dividend accruing on existing deferred stock units, with a reported per-share price of $0.0000.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:14 PM Accepted by SEC EDGAR 09/10/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wills Kevin

(Last) (First) (Middle)

2400 MARKET STREET

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		A		34.551(1)	A	$0	21,974.546	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)